New Guidance for Bioscience Startups The CARES Act was signed March 27th with the goal to inject liquidity into an American economy profoundl.....

While our team spends the week absorbing the latest in healthcare investing trends and evangelizing for our fundraising portfolio companies, we asked one of them what it takes for a company to be successful in the search for backing.

This article originally appeared in Smart Business Dealmakers Cleveland, Nov. 12, 2019 Talent is the key to building a vibrant entrepreneurial .....

President and CEO of BioEnterprise, Aram Nerpouni, sheds light on the biomedical investment and innovation climate in the Midwest and how Cleveland is contributing to the region’s growth

The recent announcement that BioEnterprise and Accenture have formed a Cleveland-based working group, at the Global Center, to fight opioid addiction represents a noteworthy collaborative effort to address a national scourge. The working group was created after the second of the Global Center’s Executive Briefing Series, which is attracting thought leaders from across the country eager to take on some of society’s greatest healthcare challenges.

Aram Nerpouni
As a sign of the Midwest’s continued growth as an engine of biomedical commercialization, a record 375 Midwest healthcare companies raised $1.7 billion in 2016, the second largest amount recorded.

Vijay Iyer, Ph.D.
Gatekeepers, as with many organizations, control access to hospital purchasers, and that control brings both great power and great responsability. Hospital purchasing gatekeepers are officially known as the value analysis…

Tim Miller, Ph.D.
I’m the president and CEO of a publicly traded bioscience company who recently decided to locate and expand my company, Abeona Therapeutics, in Northeast Ohio instead of any other state or region